Ladenburg Thalmann Financial Services’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $0 | Hold |
265
| – | – | ﹤0.01% | 5583 |
|
2019
Q3 | $0 | Hold |
265
| – | – | ﹤0.01% | 5534 |
|
2019
Q2 | $0 | Hold |
265
| – | – | ﹤0.01% | 5479 |
|
2019
Q1 | $0 | Hold |
265
| – | – | ﹤0.01% | 5405 |
|
2018
Q4 | $0 | Buy |
265
+245
| +1,225% | – | ﹤0.01% | 5406 |
|
2018
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 5381 |
|
2018
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 5179 |
|
2018
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 5247 |
|
2017
Q4 | $0 | Sell |
20
-3,550
| -99% | – | ﹤0.01% | 5160 |
|
2017
Q3 | $12K | Sell |
3,570
-35,110
| -91% | -$118K | ﹤0.01% | 4006 |
|
2017
Q2 | $159K | Hold |
38,680
| – | – | ﹤0.01% | 2189 |
|
2017
Q1 | $55K | Hold |
38,680
| – | – | ﹤0.01% | 2839 |
|
2016
Q4 | $62K | Sell |
38,680
-163
| -0.4% | -$261 | ﹤0.01% | 2688 |
|
2016
Q3 | $76K | Buy |
38,843
+2,200
| +6% | +$4.31K | ﹤0.01% | 2455 |
|
2016
Q2 | $82K | Sell |
36,643
-2,200
| -6% | -$4.92K | ﹤0.01% | 2300 |
|
2016
Q1 | $126K | Sell |
38,843
-45
| -0.1% | -$146 | ﹤0.01% | 1909 |
|
2015
Q4 | $163K | Hold |
38,888
| – | – | ﹤0.01% | 1720 |
|
2015
Q3 | $158K | Buy |
38,888
+20,045
| +106% | +$81.4K | ﹤0.01% | 1651 |
|
2015
Q2 | $54K | Sell |
18,843
-15,450
| -45% | -$44.3K | ﹤0.01% | 2533 |
|
2015
Q1 | $116K | Sell |
34,293
-2,917
| -8% | -$9.87K | ﹤0.01% | 1980 |
|
2014
Q4 | $260K | Buy |
37,210
+1,150
| +3% | +$8.04K | 0.01% | 1260 |
|
2014
Q3 | $288K | Hold |
36,060
| – | – | 0.01% | 1035 |
|
2014
Q2 | $418K | Hold |
36,060
| – | – | 0.01% | 843 |
|
2014
Q1 | $507K | Sell |
36,060
-1,542
| -4% | -$21.7K | 0.01% | 721 |
|
2013
Q4 | $999K | Hold |
37,602
| – | – | 0.03% | 444 |
|
2013
Q3 | $1.29M | Buy |
37,602
+292
| +0.8% | +$10K | 0.04% | 332 |
|
2013
Q2 | $1.17M | Buy |
+37,310
| New | +$1.17M | 0.04% | 352 |
|